Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 1184-1185

  Bassez, Clémence ^a,b,c   Deharo, Pierre ^a,b,c   Pankert, Mathieu ^a,b,c   Bonnet, Guillaume ^a,b,c   Quilici, Jacques ^a,b,c   Lambert, Marc ^a,b,c   Verdier, Valentine ^d   Morange, Pierre ^a,b,c   Alessi, Marie Christine ^a,b,c   Bonnet, Jean Louis ^a,b,c   Cuisset, Thomas ^a,b,c  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Acute coronary syndrome; High on treatment platelet reactivity; Platelets; Prasugrel; Ticagrelor

Indexed keywords

ADENOSINE; PIPERAZINE DERIVATIVE; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; THIOPHENE DERIVATIVE; TICAGRELOR;

ACUTE CORONARY SYNDROME; ANALOGS AND DERIVATIVES; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE CARE; PROCEDURES; RECURRENT DISEASE; RETROSPECTIVE STUDY; THROMBOSIS;

ACUTE CORONARY SYNDROME; ADENOSINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PIPERAZINES; POSTOPERATIVE CARE; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECURRENCE; RETROSPECTIVE STUDIES; THIOPHENES; THROMBOSIS;

EID: 84908255672     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.239     Document Type: Article

References (9)

1. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)(1), P.G. Steg, and S.K. James ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
2. S.R. Mehta, S. Yusuf, and R.J. Peters Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
3. S.D. Wiviott, E. Braunwald, and C.H. McCabe Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
4. L. Wallentin, R.C. Becker, A. Budaj R.A. Harrington, PLATO Investigators, A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 36 2009 [1045-1057.5]
5. D. Trenk, G.W. Stone, and M. Gawaz A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI study J Am Coll Cardiol 59 24 2012 2159 2164
6. P. Deharo, C. Bassez, and G. Bonnet Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison Int J Cardiol 170 2 2013 e21 e22
7. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
8. L. Bonello, M. Pansieri, and J. Mancini High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 5 2011 467 473
9. D. Alexopoulos, I. Xanthopoulou, and S. Deftereos In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome Am Heart J 167 1 2013 68-76.e2